Home LiteratureArticle Details
PMID: 16731834 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation.

Diabetes ·Vol. 55 ·No. 6 ·2006-06-00 ·Pages 1713-22

Sagen JV, Odili S, Bjørkhaug L, Zelent D, Buettger C, Kwagh J, Stanley C, Dahl-Jørgensen K, de Beaufort C, Bell GI, Han Y, Grimsby J, Taub R, Molven A, Søvik O, Njølstad PR, Matschinsky FM

Abstract

Glucokinase functions as a glucose sensor in pancreatic beta-cells and regulates hepatic glucose metabolism. A total of 83 probands were referred for a diagnostic screening of mutations in the glucokinase (GCK) gene. We found 11 different mutations (V62A, G72R, L146R, A208T, M210K, Y215X, S263P, E339G, R377C, S453L, and IVS5 + 1G>C) in 14 probands. Functional characterization of recombinant glutathionyl S-transferase-G72R glucokinase showed slightly increased activity, whereas S263P and G264S had near-normal activity. The other point mutations were inactivating. S263P showed marked thermal instability, whereas the stability of G72R and G264S differed only slightly from that of wild type. G72R and M210K did not respond to an allosteric glucokinase activator (GKA) or the hepatic glucokinase regulatory protein (GKRP). Mutation analysis of the role of glycine at position 72 by substituting E, F, K, M, S, or Q showed that G is unique since all these mutants had very low or no activity and were refractory to GKRP and GKA. Structural analysis provided plausible explanations for the drug resistance of G72R and M210K. Our study provides further evidence that protein instability in combination with loss of control by a putative endogenous activator and GKRP could be involved in the development of hyperglycemia in maturity-onset diabetes of the young, type 2. Furthermore, based on data obtained on G264S, we propose that other and still unknown mechanisms participate in the regulation of glucokinase.

MeSH Terms
Binding Sites Blood Glucose/metabolism Carrier Proteins/metabolism Crystallography, X-Ray Diabetes Mellitus, Type 2/genetics,pathology,prevention & control Enzyme Stability/drug effects Genetic Testing Glucokinase/chemistry,genetics,metabolism Glucose/pharmacology Humans Hyperglycemia/enzymology,genetics,metabolism Kinetics Mutant Proteins/chemistry,metabolism Mutation Protein Binding Protein Structure, Secondary Protein Structure, Tertiary
Chemicals
Blood Glucose Carrier Proteins Mutant Proteins glucokinase regulatory protein Glucokinase Glucose
Authors & Affiliations
17 authors, click to expand affiliations / ORCID
Sagen Jørn V
Section for Pediatrics, Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Odili Stella
Bjørkhaug Lise
Zelent Dorothy
Buettger Carol
Kwagh Jae
Stanley Charles
Dahl-Jørgensen Knut
de Beaufort Carine
Bell Graeme I
Han Yi
Grimsby Joseph
Taub Rebecca
Molven Anders
Søvik Oddmund
Njølstad Pål R
Matschinsky Franz M
Article Info
Journal
Diabetes
Abbr.
Diabetes
ISSN
0012-1797
Published
2006-06-00
Pages
1713-22
Language
English
Region
United States
NLM ID
0372763
Subset
IM
Grants
NIDDK NIH HHS · DK 19525 · United States
NIDDK NIH HHS · DK 22122 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]